FUSE MEDICAL, INC.: 10-Q filed 2013-01-22

Name: FUSE MEDICAL, INC.: 10-Q filed 2013-01-22
Creator: FUSE MEDICAL, INC.

What FUSE MEDICAL, INC. reported in its quarterly report filed 2013-01-22 (fiscal Q1 2013): 12 published measures, 25 facts as tagged in accession 0001477932-13-000307.

This filing

Form: 10-Q (quarterly report)
Filed: 2013-01-22
Fiscal period: fiscal Q1 2013
Accession: 0001477932-13-000307 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All FUSE MEDICAL, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-11-30	3,559	USD
At 2012-08-31	5,524	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2012-11-30	-76,362	USD
At 2012-08-31	-44,190	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2012-11-30	244	USD
At 2012-08-31	334	USD
At 2011-11-30	48,314	USD
At 2011-08-31	53,401	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-09-01 to 2012-11-30	-32,172	USD	91
2011-09-01 to 2011-11-30	-29,122	USD	91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2012-09-01 to 2012-11-30	-90	USD	91
2011-09-01 to 2011-11-30	-5,087	USD	91

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2012-11-30	-3,290,585	USD
At 2012-08-31	-3,258,413	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-09-01 to 2012-11-30	-32,172	USD	91
2011-09-01 to 2011-11-30	-29,137	USD	91

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-11-30	3,559	USD
At 2012-08-31	5,524	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-11-30	79,921	USD
At 2012-08-31	49,714	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2012-09-01 to 2012-11-30	32,172	USD	91
2011-09-01 to 2011-11-30	29,137	USD	91

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2012-11-30	3,567,377	shares
At 2012-08-31	3,567,377	shares

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2011-09-01 to 2011-11-30	15	USD	91

Inspect the source

Entity: FUSE MEDICAL, INC. / CIK 0000319016
Captured: 2026-09-19T11:14:02.031Z
SEC response SHA-256: 13d41024642d3becfdbc15fe6e31fdae11d4fa7a32679fcba6c1a612c57d756a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000319016.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))